Skip to main content
Log in

Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours

  • Head and Neck
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To explore the correlations of conventional MRI (cMRI) and diffusion tensor imaging (DTI) values with the 1p/19 codeletion and IDH mutations in oligodendroglial tumours (OTs).

Methods

Eighty-four patients with OTs who underwent cMRI and DTI were retrospectively reviewed. The maximal fractional anisotropy and minimal apparent diffusion coefficient (ADC) were measured and compared using the Mann-Whitney U test. Receiver operating characteristic curves, logistic regression analysis and four-table statistics analysis were performed to predict genotypings.

Results

OTs with 1p/19q codeletion or IDH mutations were prone to locate in frontal (P = 0.106 and 0.005, respectively) and insular lobes and were associated with absent or blurry contrast enhancement (P = 0.040 and 0.013, respectively). DTI values showed significant differences between OTs with and without IDH mutations (P < 0.05) but not in OTs with and without 1p/19q loss. The Ki-67 index significantly correlated with IDH mutations (P = 0.002) but not with 1p/19q codeletion. A combination of DTI and cMRI for the identification of IDH mutations resulted in sensitivity, specificity, positive and negative predictive values of 92.2 %, 75.8 %, 93.8 % and 71.1 %, respectively.

Conclusions

Combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in OTs.

Key Points

OTs with 1p/19q codeletion were associated with absent or blurry contrast enhancement

OTs with IDH mutations were also associated with absent or blurry contrast enhancement

OTs with IDH mutations were prone to locate in frontal and insular lobes

DTI values can provide a non-invasive method for assessing the IDH status of OTs

A combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AUC:

Area under the curve

cMRI:

Conventional MRI

FA:

Fractional anisotropy

IDH:

Isocitrate dehydrogenase

OTs:

Oligodendroglial tumours

rmADC:

Ratio of minimal ADC

rmFA:

Ratio of maximal FA

References

  1. Bromberg JE, van den Bent MJ (2009) Oligodendrogliomas: molecular biology and treatment. Oncologist 14:155–163

    Article  CAS  PubMed  Google Scholar 

  2. Reifenberger G, Kros JM, Louis DN, Collins VP (2007) Oligodendroglioma and Anaplastic oligodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD (eds) WHO Classification of Tumors of the Central Nervous System. IARC, Lyon, pp 54–62

    Google Scholar 

  3. Jaeckle KA, Ballman KV, Rao RD, Jenkins RB, Buckner JC (2006) Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response. J Clin Oncol 24:1246–1252

    Article  CAS  PubMed  Google Scholar 

  4. van den Bent MJ, Brandes AA et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344–350

    Article  PubMed  Google Scholar 

  5. Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149–1153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sanson M, Marie Y, Paris S et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150–4154

    Article  CAS  PubMed  Google Scholar 

  9. Frenel JC, Leux C, Loussouarn D et al (2013) Combining two biomarkers, IDH mutationss and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience. J Neurooncol 114:85–91

    Article  CAS  PubMed  Google Scholar 

  10. Jenkinson MD, Smith TS, Brodbelt AR et al (2007) Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 26:1405–1412

    Article  PubMed  Google Scholar 

  11. Fellah S, Caudal D, De Paula AM et al (2013) Multimodal MR Imaging (Diffusion, Perfusion, and Spectroscopy): Is It Possible to Distinguish Oligodendroglial Tumor Grade and 1p/19q Codeletion in the Pretherapeutic Diagnosis? AJNR Am J Neuroradiol 34:1326–1333

    Article  CAS  PubMed  Google Scholar 

  12. Jenkinson MD, Smith TS, Joyce KA et al (2006) Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumors. Neuroradiology 48:703–713

    Article  PubMed  PubMed Central  Google Scholar 

  13. Tan WL, Huang WY, Yin B, Xiong J, Wu JS, Geng DY (2014) Can diffusion tensor imaging noninvasively detect IDH1 gene mutations in astrogliomas? A retrospective study of 112 cases. AJNR Am J Neuroradiol 35:920–927

    Article  CAS  PubMed  Google Scholar 

  14. White ML, Zhang Y, Yu F, Jaffar Kazmi SA (2011) Diffusion tensor MR imaging of cerebral gliomas: evaluating fractional anisotropy characteristics. AJNR Am J Neuroradiol 32:374–381

    Article  CAS  PubMed  Google Scholar 

  15. Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487

    CAS  PubMed  Google Scholar 

  16. Brander A, Kataja A, Saastamoinen A et al (2010) Diffusion tensor imaging of the brain in a healthy adult population: normative values and measurement reproducibility at 3T and 1.5T. Acta Radiol 51:800–807

    Article  PubMed  Google Scholar 

  17. Wang Y, Xiong J, Chu SG et al (2009) Rosette-forming glioneuronal tumor: report of an unusual case with intraventricular dissemination. Acta Neuropathol 118:813–819

    Article  PubMed  Google Scholar 

  18. Lass U, Hartmann C, Capper D et al (2013) Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Brain Pathol 23:311–318

    Article  CAS  PubMed  Google Scholar 

  19. Preusser M, Hoeftberger R, Woehrer A et al (2012) Prognostic value of Ki67 index in anaplastic oligodendroglial tumors--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Histopathology 60:885–894

    Article  PubMed  Google Scholar 

  20. Takano S, Tian W, Matsuda M et al (2011) Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing. Brain Tumor Pathol 28:115–123

    Article  CAS  PubMed  Google Scholar 

  21. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310

    Article  CAS  PubMed  Google Scholar 

  22. Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C (2006) Histological growth patterns and genotype in oligodendroglial tumors: correlation with MRI features. Brain 129:1884–1891

    Article  PubMed  Google Scholar 

  23. Megyesi JF, Kachur E, Lee DH et al (2004) Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 10:4303–4306

    Article  PubMed  Google Scholar 

  24. German RB, Dehais C, Idbaih A et al (2014) Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Neuro Oncol 16:662–670

    Article  Google Scholar 

  25. Jolapara M, Patro SN, Kesavadas C et al (2011) Can diffusion tensor metrics help in preoperative grading of diffusely infiltrating astrocytomas? A retrospective study of 36 cases. Neuroradiology 53:63–68

    Article  PubMed  Google Scholar 

  26. Kitis O, Altay H, Calli C et al (2005) Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 55:393–400

    Article  PubMed  Google Scholar 

  27. Mori N, Ota H, Mugikura S, Takasawa C et al (2015) Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology 274:66–73

    Article  PubMed  Google Scholar 

  28. Fudaba H, Shimomura T, Abe T et al (2014) Comparison of multiple parameters obtained on 3 T pulsed arterial spin-labeling, diffusiontensor imaging and MRS and the Ki-67 labeling index in evaluating glioma grading. AJNR Am J Neuroradiol 35:2091–2098

    Article  CAS  PubMed  Google Scholar 

  29. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297–310

    Article  CAS  PubMed  Google Scholar 

  30. Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT (2010) Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol 194:1160–1166

    Article  PubMed  Google Scholar 

  31. Uematsu T, Kasami M, Yuen S (2009) Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 250:638–647

    Article  PubMed  Google Scholar 

  32. Kapoor GS, Gocke TA, Chawla S et al (2009) Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status. J Neurooncol 92:373–386

    Article  PubMed  Google Scholar 

  33. Xu W, Yang H, Liu Y et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Olar A, Raghunathan A, Albarracin CT et al (2012) Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol 16:161–170

    Article  PubMed  Google Scholar 

  35. Wang S, Kim S, Chawla S et al (2009) Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 44:653–660

    Article  PubMed  PubMed Central  Google Scholar 

  36. Beppu T, Inoue T, Shibata Y et al (2005) Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas. Surg Neurol 63:56–61

    Article  PubMed  Google Scholar 

  37. Louis DN, Perry A, Burger P et al (2014) International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Ji Xiong and Wenli Tan contributed equally to this paper. The scientific guarantor of this publication is Daoying Geng. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This study has received funding from a grant from the National Nature Science Foundation of China (No. 81402051) to Ji Xiong, and the National Nature Science Foundation of China (No. 81471627), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20130071130011), and the Shanghai Health System Important Disease Joint Research Project (No. 2013ZYJB009) to Daoying Geng, and the National Nature Science Foundation of China (No. 81201071), the Science and Technical Committee of Shanghai Municipality (No. 12ZR1441600) and Outstanding Youth Grant from Shanghai Municipal Commission of Health and Family Planning (No. XYQ2013107) to Jun Zhang. Xiaoqin Wang kindly provided statistical advice for this manuscript. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board. Methodology: retrospective, experimental, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jun Zhang or Daoying Geng.

Additional information

Ji Xiong and Wenli Tan contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Fig. S1

(DOC 2319 kb)

Table S1

(DOC 86 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiong, J., Tan, W., Wen, J. et al. Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours. Eur Radiol 26, 1705–1715 (2016). https://doi.org/10.1007/s00330-015-4025-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-4025-4

Keywords

Navigation